Spots Global Cancer Trial Database for alvocidib
Every month we try and update this database with for alvocidib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia | NCT00098371 | B-cell Chronic ... Prolymphocytic ... Refractory Chro... | alvocidib | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer That Has Not Responded to Previous Paclitaxel | NCT00006245 | Esophageal Canc... | alvocidib paclitaxel | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma | NCT00003039 | Lymphoma | alvocidib | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | NCT00072436 | Unspecified Adu... | gemcitabine hyd... alvocidib pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia | NCT00101231 | Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Blastic Phase C... Recurrent Adult... Recurrent Adult... Relapsing Chron... | alvocidib | 1 Year - | National Cancer Institute (NCI) | |
| Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors | NCT00007917 | Unspecified Adu... | alvocidib gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma | NCT00005974 | Sarcoma | alvocidib | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | NCT00020189 | Head and Neck C... Thromboembolism | acetylsalicylic... alvocidib clopidogrel bis... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Recurrent Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma | NCT00003039 | Lymphoma | alvocidib | 18 Years - | National Cancer Institute (NCI) | |
| Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT00634244 | Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... | alvocidib mitoxantrone hy... carboplatin cytarabine sirolimus etoposide topotecan hydro... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT01349972 | Acute Myeloid L... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult... | alvocidib daunorubicin hy... mitoxantrone hy... cytarabine | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors | NCT00003004 | Unspecified Adu... | alvocidib cisplatin paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors | NCT00006485 | Unspecified Adu... | alvocidib irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia | NCT00278330 | Blastic Phase C... Recurrent Adult... Recurrent Adult... Refractory Anem... Relapsing Chron... Untreated Adult... Untreated Adult... | alvocidib vorinostat | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial Cancer | NCT00023894 | Endometrial Can... | alvocidib | - | National Cancer Institute (NCI) | |
| Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery | NCT00098579 | Gastrointestina... Recurrent Adult... Stage IV Adult ... | alvocidib doxorubicin hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer | NCT00016939 | Kidney Cancer | alvocidib | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Solid Tumors | NCT00042874 | Unspecified Adu... | alvocidib irinotecan hydr... fluorouracil leucovorin calc... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | NCT00003690 | Breast Cancer Melanoma (Skin) Prostate Cancer Unspecified Adu... | alvocidib carboplatin cisplatin | 18 Years - | Mayo Clinic | |
| Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT00016185 | Unspecified Adu... | alvocidib docetaxel | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer | NCT00331682 | Adenocarcinoma ... Recurrent Pancr... Stage IV Pancre... | alvocidib docetaxel | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Metastatic Malignant Melanoma | NCT00005971 | Melanoma (Skin) | alvocidib | 18 Years - 120 Years | Canadian Cancer Trials Group | |
| Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors | NCT00324480 | Unspecified Adu... | alvocidib vorinostat pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer | NCT00047307 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | alvocidib gemcitabine hyd... 3-dimensional c... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer | NCT00016939 | Kidney Cancer | alvocidib | - | National Cancer Institute (NCI) | |
| Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer | NCT00064285 | Leukemia | alvocidib imatinib mesyla... | 18 Years - | Virginia Commonwealth University | |
| Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors | NCT00003004 | Unspecified Adu... | alvocidib cisplatin paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia | NCT00470197 | Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Malignant Neopl... Recurrent Adult... Recurrent Adult... | alvocidib cytarabine mitoxantrone hy... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia | NCT00003620 | B-cell Chronic ... Refractory Chro... Stage I Chronic... Stage II Chroni... Stage III Chron... Stage IV Chroni... | alvocidib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer | NCT00016939 | Kidney Cancer | alvocidib | - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Recurrent Prostate Cancer | NCT00003256 | Prostate Cancer | alvocidib | - | National Cancer Institute (NCI) | |
| Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia | NCT00407966 | Adult Acute Bas... Adult Acute Eos... Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Secondary Acute... Untreated Adult... | alvocidib cytarabine mitoxantrone hy... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol and Irinotecan in Treating Patients With Advanced Solid Tumors | NCT00006485 | Unspecified Adu... | alvocidib irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Advanced Cancer | NCT00021073 | Unspecified Adu... | alvocidib leucovorin calc... fluorouracil irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol, Gemcitabine, and Irinotecan in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT00079352 | Unspecified Adu... | alvocidib gemcitabine hyd... irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Alvocidib, Oxaliplatin, Fluorouracil, and Leucovorin Calcium in Treating Patients With Advanced Solid Tumors | NCT00080990 | Unspecified Adu... | alvocidib fluorouracil oxaliplatin leucovorin calc... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer | NCT00064285 | Leukemia | alvocidib imatinib mesyla... | 18 Years - | Virginia Commonwealth University | |
| Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery | NCT00991952 | Adenocarcinoma ... Diffuse Adenoca... Intestinal Aden... Mixed Adenocarc... Recurrent Gastr... Stage IIIA Gast... Stage IIIB Gast... Stage IIIC Gast... Stage IV Gastri... | alvocidib irinotecan hydr... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma | NCT00058240 | B-cell Chronic ... Recurrent Small... Refractory Chro... Waldenström Mac... | alvocidib | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | NCT00003690 | Breast Cancer Melanoma (Skin) Prostate Cancer Unspecified Adu... | alvocidib carboplatin cisplatin | 18 Years - | Mayo Clinic | |
| Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | NCT00072436 | Unspecified Adu... | gemcitabine hyd... alvocidib pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | NCT00020189 | Head and Neck C... Thromboembolism | acetylsalicylic... alvocidib clopidogrel bis... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer | NCT00087282 | Liver Cancer | alvocidib irinotecan hydr... | 18 Years - | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma | NCT00058240 | B-cell Chronic ... Recurrent Small... Refractory Chro... Waldenström Mac... | alvocidib | 18 Years - | National Cancer Institute (NCI) | |
| Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT00634244 | Adult Acute Meg... Adult Acute Min... Adult Acute Mon... Adult Acute Mon... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Erythrole... Adult Pure Eryt... Recurrent Adult... | alvocidib mitoxantrone hy... carboplatin cytarabine sirolimus etoposide topotecan hydro... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia | NCT00003620 | B-cell Chronic ... Refractory Chro... Stage I Chronic... Stage II Chroni... Stage III Chron... Stage IV Chroni... | alvocidib laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors | NCT00003004 | Unspecified Adu... | alvocidib cisplatin paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | NCT00016185 | Unspecified Adu... | alvocidib docetaxel | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Combination Chemotherapy in Treating Patients With Refractory or Recurrent Solid Tumors | NCT00003004 | Unspecified Adu... | alvocidib cisplatin paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Vorinostat and Alvocidib in Treating Patients With Advanced Solid Tumors | NCT00324480 | Unspecified Adu... | alvocidib vorinostat pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML). | NCT03298984 | Acute Myeloid L... | Alvocidib Cytarabine Daunorubicin | 18 Years - 65 Years | Sumitomo Pharma America, Inc. | |
| Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00377104 | B-cell Chronic ... Contiguous Stag... Noncontiguous S... Stage I Chronic... Stage I Small L... Stage II Chroni... Stage III Chron... Stage III Small... Stage IV Chroni... Stage IV Small ... | alvocidib pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | NCT00377104 | B-cell Chronic ... Contiguous Stag... Noncontiguous S... Stage I Chronic... Stage I Small L... Stage II Chroni... Stage III Chron... Stage III Small... Stage IV Chroni... Stage IV Small ... | alvocidib pharmacological... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Alvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell Lymphoma | NCT00058227 | B-cell Chronic ... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Contiguous Stag... Extranodal Marg... Nodal Marginal ... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Noncontiguous S... Progressive Hai... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Refractory Chro... Refractory Hair... Splenic Margina... Stage I Chronic... Stage I Grade 1... Stage I Grade 2... Stage I Mantle ... Stage I Margina... Stage I Small L... Stage II Chroni... Stage III Chron... Stage III Grade... Stage III Grade... Stage III Mantl... Stage III Margi... Stage III Small... Stage IV Chroni... Stage IV Grade ... Stage IV Grade ... Stage IV Mantle... Stage IV Margin... Stage IV Small ... Untreated Hairy... Waldenström Mac... | alvocidib fludarabine pho... rituximab pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Alvocidib Biomarker-driven Phase 2 AML Study | NCT02520011 | Acute Myeloid L... | Alvocidib Cytarabine Mitoxantrone | 18 Years - 65 Years | Sumitomo Pharma America, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
